MedTrace Logo

Phase III Trial of Stage I Ovarian Cancer After Surgery

NCT04063527 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2019-08-30

No results posted yet for this study

Summary

To compare the Overall survival of adjuvant chemotherapy versus observation in stage I epithelial ovarian cancer after comprehensive staging surgery

Conditions

  • Epithelial Ovarian Cancer

Interventions

DRUG

adjuvant chemotherapy

combination of paclitaxel and carboplatin

Sponsors & Collaborators

  • Korean Gynecologic Oncology Group

    collaborator OTHER

  • Japanese Gynecologic Oncology Group

    lead OTHER

Principal Investigators

  • Hiroshi Tanabe, M.D. · National Cancer Center Hospital East

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-20
Primary Completion
2029-10-01
Completion
2030-02-01

Countries

  • Japan
  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04063527 on ClinicalTrials.gov